Dipeptidyl peptidase-4 inhibitory potentials of Glycyrrhiza uralensis and its bioactive compounds licochalcone A and licochalcone B: An in silico and in vitro study
Type 2 diabetes mellitus (T2DM) is a growing global public health issue, and dipeptidyl peptidase-4 (DPP-4) is a potential therapeutic target in T2DM. Several synthetic anti-DPP-4 medications can be used to treat T2DM. However, because of adverse effects, there is an unmet demand for the development...
Guardat en:
| Autors principals: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Frontiers Media S.A.
2022-09-01
|
| Col·lecció: | Frontiers in Molecular Biosciences |
| Matèries: | |
| Accés en línia: | https://www.frontiersin.org/articles/10.3389/fmolb.2022.1024764/full |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|